CARB-X Awards Baebies up to $11.6 Million
Wednesday, May 26
This non-dilutive funding will support the development of a near-patient and rapid diagnostic platform for sepsis–specially focused on addressing the unique needs of neonatal and pediatric populations.
The CARB-X award consists of $3.9 million in initial funding with up to $7.7 million of milestone-based funding. CARB-X, a global non-profit partnership, provides funding and support for projects that target drug-resistant bacteria.
Why sepsis? And why newborns? Learn more in the full release.
Copyright © 2021 Baebies, Inc., All rights reserved.
Baebies, Inc., 615 Davis Drive, Suite 800, Durham, NC 27709, USA
View our Privacy Policy.